Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Net Income: 2009-2025

Historic Net Income for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $38.2 million.

  • BIO-TECHNE's Net Income rose 13.65% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year decrease of 75.73%. This contributed to the annual value of $22.2 million for FY2025, which is 82.61% down from last year.
  • Per BIO-TECHNE's latest filing, its Net Income stood at $38.2 million for Q3 2025, which was up 155.48% from -$68.8 million recorded in Q2 2025.
  • Over the past 5 years, BIO-TECHNE's Net Income peaked at $89.7 million during Q3 2022, and registered a low of -$68.8 million during Q2 2025.
  • Over the past 3 years, BIO-TECHNE's median Net Income value was $34.9 million (recorded in 2024), while the average stood at $27.7 million.
  • Per our database at Business Quant, BIO-TECHNE's Net Income soared by 563.12% in 2022 and then crashed by 16,219.44% in 2025.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Net Income stood at $72.1 million in 2021, then plummeted by 30.61% to $50.0 million in 2022, then crashed by 45.08% to $27.5 million in 2023, then rose by 27.03% to $34.9 million in 2024, then increased by 13.65% to $38.2 million in 2025.
  • Its last three reported values are $38.2 million in Q3 2025, -$68.8 million for Q2 2025, and $22.6 million during Q1 2025.